The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

Testing on June 7 by utility Aqua found elevated nitrate levels in water from the Kankakee River. Nitrates can be harmful to ...

The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year ...

Antibiotic use in preterm infants is linked to gut microbiome changes, increasing susceptibility to infections and impacting ...

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...

Screening can now determine their risk for an ever-growing list of conditions — including ones we can’t do much about.

As newborn screening and rapid DNA sequencing become routine, we are poised to catch and treat inherited diseases at their ...

The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment.

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...

Aqua Illinois advises University Park, Peotone and Kankakee residents not to give tap water to infants due to high nitrate ...